Continuous blood glucose monitoring in diabetes treatment

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Vazeou, Andriani ^a  

^a P and A Kyriafeou Children's Hospital   (Greece)

Author keywords

Diabetes mellitus; Glucose sensors; Insulin pump; Insulin therapy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; PATIENT EDUCATION; PREDICTION; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 84860417188     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70028-6     Document Type: Article

References (48)

1. The Diabetes Control and Complications Trial Research Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995, 44:968-983.
2. Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, Waberski BH, Lachin JM, Albers JW DCCT/EDIC Research Group DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep 2010, 10(4):276-282.
3. White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD DCCT-EDIC Research Group Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 2010, 59(5):1244-1253.
4. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH DCCT/EDIC Research Group Effects of prior intensive insulin therapy on cardiac autonomie nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009, 119(22):2886-2893.
5. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353(25):2643-2653.
6. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003, 290(16):2159-2167.
7. Pickup J, Mattock M, Kerry S Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002, 324(7339):705.
8. Schoenle EJ, Schoenle D, Molinari L, Largo RH Impaired intellectual development in children with Type I diabetes: association with HbA(lc), age at diagnosis and sex. Diabetologia 2002, 45(1):108-114.
9. Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH, Hershey T Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008, 9(2):87-95.
10. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH Hershey Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007 Sep, 30(9):2331-2337.
11. Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH, Hershey T Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008, 9(2):87-95.
12. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295(14):1681-1687.
13. Ceriello A, Esposito K, Piconi L, Ihnat M, Thorpe J, Testa R, Bonfigli AR, Giugliano D Glucose " peak" and glucose " spike": Impact on endothelial function and oxidative stress. Diabetes Res Clin Pract 2008, 82(2):262-267.
14. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2007, 8:408-418.
15. Boyne MS, Silver DM, Kaplan J, Saudek CD Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003, 52(11):2790-2794.
16. Keenan DB, Cartaya R, Mastrototaro JJ Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sei Technol 2010, 4(l):111-118.
17. Wentholt IM, Hoekstra JB, DeVries JH Continuous glucose monitors: the long-awaited watch dogs?. Diabetes Technol Ther 2007, 9:399-409.
18. Mougiakakou S, Zarkogianni K, Iliopoulou D, Chatzoglou A, Thymelli I, Aggelou E, Maragou C, Stamoyannou L, Vazeou A Improvement of glycemic control in children with type 1 diabetes with continuous glucose monitoring systems (CGMS) and Guardian RT. Pediatrie Diabetes 2007, 8(Suppl 7):81.
19. The Diabetes Research in Children Network (DirecNet) Study Group The Accuracy of the Guardian(r) RT Continuous Glucose Monitor in Children with Type 1 Diabetes. Diabetes Technol Ther 2008, 10(4):266-272.
20. International Organisation for Standardization. In vitro diagnostic test systems - Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: 2003.
21. Mastrototaro J, Shin J, Marcus A, Sulur G STAR 1 Clinical Trial Investigators The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther 2008, 10(5):385-390.
22. Continuous Glucose Monitoring System (CGMS):summary of safety and effectiveness data http://www.fda.gov/cdrh/pdf/p980022b.pdf.
23. Diabetes Research In Children Network (Direcnet) Study Group, Buckingham BA, Kollman C, Beck R, Kalajian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, Tamborlane WV Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006, 8(3):318-325.
24. McGarraugh G Alarm characterization for continuous glucose monitors used as adjuncts to self-monitoring of blood glucose. J Diabetes Sei Technol 2010, 4(1):41-48.
25. McGarraugh G Alarm characterization for a continuous glucose monitor that replaces traditional blood glucose monitoring. J Diabetes Sei Technol 2010, 4(1):49-56.
26. Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J Alarms based on real-time glucose values alert patients to hypo- and hyperglycemia; the guardian continuous monitoring system. Diabetes Technol Ther 2004, 6(2):105-113.
27. http://www.freestylenavigator.com.
28. Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA DirecNet Study Group. The accuracy of the Freestyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007, 30(1):59-64.
29. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sei Technol 2009, 3(5):1146-1154.
30. http://www.medtronic.com.
31. Nardacci EA, Bode BW, Hirsch IB Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice. Diabetes Educ 2010, 36(Suppl 1):4S-19S. quiz 20S-21S.
32. Keenan DB, Cartaya R, Mastrototaro JJ Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sei Technol 2010, 4(1):111-118.
33. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002, 25(2):347-352.
34. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006, 29(12):2730-2732.
35. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008, 10(5):377-383.
36. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359(14):1464-1476.
37. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009, 32(11):1947-1953.
38. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Bode B, Beck RW, Xing D, Gilliam L, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Tamborlane WV, Weinzimer S, Wolpert H Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009, 32(11):2047-2049.
39. Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010, 12(7):507-515.
40. Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type IDiabetes. The Real Trend study. Diabetes Care 2009, 32:2245-2250.
41. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA The STAR 3 Study Group. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. N Engl J Med 2010 Jun 29, [Epub ahead of print].
42. Facchinetti A, Sparacino G, Cobelli C Modelling the error of continuous glucose monitoring sensor data: critical aspects discussed through simulation studies. J Diabetes Sei Technol 2010, 4(1):4-14.
43. Mastrototaro J, Welsh JB, Lee S Practical Considerations in the Use of Real-Time Continuous Glucose Monitoring Alerts. J Diabetes Sei Technol 2010, 4(3):733-739.
44. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011, 34(4):795-800.
45. Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovic L, Chase HP, Wilson DM, Buckingham BA, Doyle FJ Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care 2010, 33(6):1249-1254.
46. Klonoff DC, Cobelli C, Kovatchev B, Zisser HC Progress in development of an artificial pancreas. J Diabetes Sei Technol 2009, 3(5):1002-1004.
47. Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010, 33(6):1269-1274.
48. Halford J, Harris C Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy. Diabetes Technol Ther 2010, 12(3):201-205.